Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Bolt Biotherapeutics Inc (BOLT)

Bolt Biotherapeutics Inc (BOLT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Bolt Biotherapeutics Inc 900 CHESAPEAKE DRIVE REDWOOD CITY CA 94063 USA

www.boltbio.com P: 650-665-9295

Description:

Bolt Biotherapeutics Inc. is a clinical-stage immuno-oncology company. It engages in the discovery, development, and commercialization of pharmaceutical products. The company's principal product includes BDC-1001. Bolt Biotherapeutics Inc. is based in Redwood city, California.

Key Statistics

Overview:

Market Capitalization, $K 42,322
Enterprise Value, $K 31,512
Shares Outstanding, K 38,128
Annual Sales, $ 7,880 K
Annual Net Income, $ -69,200 K
Last Quarter Sales, $ 2,090 K
Last Quarter Net Income, $ -17,900 K
EBIT, $ -76,200 K
EBITDA, $ -78,840 K
60-Month Beta 0.99
% of Insider Shareholders 28.40%
% of Institutional Shareholders 86.70%
Float, K 27,300
% Float 71.60%
Short Volume Ratio 0.17

Growth:

1-Year Return -24.50%
3-Year Return -95.51%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.47 on 03/21/24
Latest Earnings Date 05/09/24
Earnings Per Share ttm -1.83
EPS Growth vs. Prev Qtr -9.30%
EPS Growth vs. Prev Year 11.32%
Annual Dividend Yield 0.00%
Next Ex-Dividends Date 08/29/14
Dividend Payout Ratio 0.00%

BOLT Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -51.18%
Return-on-Assets % -37.81%
Profit Margin % -878.17%
Debt/Equity 0.00
Price/Sales 5.57
Price/Cash Flow N/A
Price/Book 0.38
Book Value/Share 2.97
Interest Coverage -2.07
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar